Myocardial ischemia, reperfusion and free radical injury

The American Journal of Cardiology

Volumn 65, Issue 19, 1990, Pages 14-23

  Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CAPTOPRIL; ENALAPRILAT; FREE RADICAL; TEPROTIDE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CORONARY REPERFUSION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; CELL ADHESION MOLECULES; CHEMOTACTIC FACTORS; COMPLEMENT ACTIVATION; E-SELECTIN; FREE RADICALS; HUMAN; IBUPROFEN; INTERCELLULAR ADHESION MOLECULE-1; MEMBRANE GLYCOPROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NEUTROPHILS; SUPEROXIDE DISMUTASE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025369854     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(90)90120-P     Document Type: Article

References (65)

1. The wavefront phenomenon of ischemic cell death. I: myocardial infarct size vs. duration of coronary occlusion in dogs
2. Advances in thrombolytic therapy for acute myocardial infarction
3. Ultrastructural damage associated with reoxygenation of the anoxic myocardium
4. Canine myocardial reperfusion injury: its reduction by the combined administration of superoxide dismutase and catalase
5. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog
6. Role for leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by antiinflammatory drugs
7. Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, and oxygen paradox and ischemia/reperfusion injury
8. Oxygen-derived free radicals in post ischemic tissue injury
9. Leukocytes and ischemia-induced myocardial injury
10. Leukocytes, oxygen radicals and myocardial injury due to ischemia and reperfusion
11. Identification of an inducible endothelial leukocyte adhesion molecule, ELAM-1
12. Experimental acute myocardial infarction: histologic and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery
13. Accumulation of polymorphonuclear leukocytes during 3-h experimental ischemia
14. Myocardial neutrophil accumulation during reperfusion and reversible or irreversible ischemic injury
15. Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood
16. Myocardial ischemia and reperfusion: the role of oxygen radicals in tissue injury
17. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats
18. Effect of indomethacin on collateral blood flow and infarct size in the conscious dog
19. Ibuprofen inhibits granulocyte responses to inflammatory mediators
20. Salvage of ischemic myocardium by ibuprofen during infarction in the conscious dog
21. The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction
22. Prostacyclin protects ischemic-reperfused myocardium in the dog by inhibition of neutrophil activation
23. Iloprost inhibits neutrophil function in vitro and limits experimental infarct size in canine heart
24. 1: inhibition of neutrophil migration and activation
25. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats
26. C3 leukotactic factors produced by a tissue protease
27. Mechanism of complement activation after coronary artery occlusion. Evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo
28. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury
29. Complement: chemistry and pathways
30. Monokine induced gene expression of a human endothelial cell-derived neutrophil chemotactic factor
31. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist
32. Recognition of an endothelial determinant for CD-18 dependent human neutrophil adherence and transendothelial migration
33. Cytokine-mediated activation of vascular endothelium. Physiology and pathology
34. Identification of an inducible endothelial leukocyte adhesion molecule, ELAM-1
35. Prevention of pulmonary injury in isolated perfused rat lungs by activated human neutrophils preincubated with anti-Mol monoclonal antibody
36. A monoclonal antibody to membrane glycoprotein complex CD 18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo
37. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mol, Anti-CD11b) that inhibits leukocyte adhesion
38. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that inhibits leukocyte adhesion
39. Role for leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by antiinflammatory drugs
40. Ibuprofen inhibits granulocyte responses to inflammatory mediators
41. The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction
42. Relative contribution of the leukocyte molecules Mol, LFA-1, and p150,95 (leuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue-and stimulus specific
43. Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion
44. Canine myocardial reperfusion injury: its reduction by the combined administration of superoxide dismutase and catalase
45. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart
46. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues
47. Xanthine dehydrogenase to xanthine oxidase conversion in ischemic rat tissues
48. On the specificity of allopurinol and oxypurinol as inhibitors of xanthine oxidase. A pulse radiolysis determination of rate constants for reaction of allopurinol and oxypurinol with hydroxyl radicals
49. Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs
50. Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart
51. Effects of allopurinol or oxypurinol on myocardial reperfusion injury
52. Effects of D-penicillamine on a model of oxygen-derived free radical mediated tissue damage
53. Chemical radiation protection by alpha-mercaptopropionyl glycine
54. Canine myocardial reperfusion injury: protection by a free radical scavenger, N-2-mercaptopropionyl glycine
55. Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia
56. N-2-mercaptopropionylglycine improves recovery of myocardial function following reversible regional ischemia
57. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radical?
58. Oxygen-derived free radicals in post ischemic tissue injury
59. Leukocytes and ischemia-induced myocardial injury
60. Leukocytes, oxygen radicals and myocardial injury due to ischemia and reperfusion
61. Free radicals in medicine II Involvement in human disease
62. Failure of superoxide dismutase to limit myocardial infarct size in a 40 minutes ischemia/four days reperfusion model in dogs
63. A nonflow basis for the vulnerability of the subendocardium
64. Time course of reperfusion induced reversal of early myocardial expansion
65. Prolonged reperfusion attenuates the protective effect of preconditioning myocardium with a brief episode of ischemia